BR112014008925A2 - micro rnas em distúrbios de neurodegenerativos - Google Patents

Info

Publication number

BR112014008925A2

BR112014008925A2 BR112014008925-6A BR112014008925A BR112014008925A2 BR 112014008925 A2 BR112014008925 A2 BR 112014008925A2 BR 112014008925 A BR112014008925 A BR 112014008925A BR 112014008925 A2 BR112014008925 A2 BR 112014008925A2

Authority

BR

Brazil

Prior art keywords

mir

hsa

level

individual

micrornas

Prior art date

2011-10-11

Links

• Espacenet
• Global Dossier
• Discuss

• 208000015122 neurodegenerative disease Diseases 0.000 title abstract description 162
• 108091070501 miRNA Proteins 0.000 title abstract description 32
• 108700011259 MicroRNAs Proteins 0.000 claims abstract description 508
• 210000001616 monocyte Anatomy 0.000 claims abstract description 310
• 206010002026 amyotrophic lateral sclerosis Diseases 0.000 claims abstract description 287
• 210000001175 cerebrospinal fluid Anatomy 0.000 claims abstract description 200
• 238000000034 method Methods 0.000 claims abstract description 195
• 238000011282 treatment Methods 0.000 claims abstract description 71
• 230000007423 decrease Effects 0.000 claims abstract description 69
• 206010061818 Disease progression Diseases 0.000 claims abstract description 39
• 230000005750 disease progression Effects 0.000 claims abstract description 39
• 101000946889 Homo sapiens Monocyte differentiation antigen CD14 Proteins 0.000 claims description 397
• 102100035877 Monocyte differentiation antigen CD14 Human genes 0.000 claims description 397
• 150000007523 nucleic acids Chemical class 0.000 claims description 175
• 102000039446 nucleic acids Human genes 0.000 claims description 158
• 108020004707 nucleic acids Proteins 0.000 claims description 158
• 101000917858 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-A Proteins 0.000 claims description 133
• 101000917839 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-B Proteins 0.000 claims description 133
• 102100029185 Low affinity immunoglobulin gamma Fc region receptor III-B Human genes 0.000 claims description 133
• -1 hsa-miR-518f Proteins 0.000 claims description 130
• 239000002679 microRNA Substances 0.000 claims description 125
• 108091067005 Homo sapiens miR-328 stem-loop Proteins 0.000 claims description 122
• 230000001965 increasing effect Effects 0.000 claims description 97
• 108091069088 Homo sapiens miR-150 stem-loop Proteins 0.000 claims description 94
• 108091063565 Homo sapiens miR-532 stem-loop Proteins 0.000 claims description 90
• 125000003729 nucleotide group Chemical group 0.000 claims description 78
• 239000002773 nucleotide Substances 0.000 claims description 74
• 208000024891 symptom Diseases 0.000 claims description 63
• 108091065981 Homo sapiens miR-155 stem-loop Proteins 0.000 claims description 58
• 239000003112 inhibitor Substances 0.000 claims description 55
• 108091068993 Homo sapiens miR-142 stem-loop Proteins 0.000 claims description 47
• 108091034117 Oligonucleotide Proteins 0.000 claims description 47
• 230000000295 complement effect Effects 0.000 claims description 47
• 108091070493 Homo sapiens miR-21 stem-loop Proteins 0.000 claims description 38
• 108091066899 Homo sapiens miR-340 stem-loop Proteins 0.000 claims description 38
• 108091008065 MIR21 Proteins 0.000 claims description 38
• 108091069527 Homo sapiens miR-223 stem-loop Proteins 0.000 claims description 37
• 230000002401 inhibitory effect Effects 0.000 claims description 35
• 108091067470 Homo sapiens miR-204 stem-loop Proteins 0.000 claims description 32
• 108091061665 Homo sapiens miR-421 stem-loop Proteins 0.000 claims description 32
• 108091061778 Homo sapiens miR-615 stem-loop Proteins 0.000 claims description 32
• 239000002243 precursor Substances 0.000 claims description 32
• 108091069013 Homo sapiens miR-206 stem-loop Proteins 0.000 claims description 31
• 108091086503 Homo sapiens miR-450b stem-loop Proteins 0.000 claims description 31
• 108091063765 Homo sapiens miR-584 stem-loop Proteins 0.000 claims description 31
• 108091061789 Homo sapiens miR-603 stem-loop Proteins 0.000 claims description 31
• 108091061680 Homo sapiens miR-655 stem-loop Proteins 0.000 claims description 31
• 108091044816 Homo sapiens miR-1297 stem-loop Proteins 0.000 claims description 30
• 108091068985 Homo sapiens miR-137 stem-loop Proteins 0.000 claims description 30
• 108091067995 Homo sapiens miR-192 stem-loop Proteins 0.000 claims description 29
• 108091086634 Homo sapiens miR-300 stem-loop Proteins 0.000 claims description 29
• 108091063777 Homo sapiens miR-548b stem-loop Proteins 0.000 claims description 28
• 108091063719 Homo sapiens miR-580 stem-loop Proteins 0.000 claims description 25
• 239000007924 injection Substances 0.000 claims description 23
• 238000002347 injection Methods 0.000 claims description 23
• 239000000074 antisense oligonucleotide Substances 0.000 claims description 17
• 238000012230 antisense oligonucleotides Methods 0.000 claims description 17
• 230000008859 change Effects 0.000 claims description 15
• 108090000994 Catalytic RNA Proteins 0.000 claims description 11
• 102000053642 Catalytic RNA Human genes 0.000 claims description 11
• 125000002091 cationic group Chemical group 0.000 claims description 11
• 108091092562 ribozyme Proteins 0.000 claims description 11
• 229920006317 cationic polymer Polymers 0.000 claims description 10
• 239000000523 sample Substances 0.000 claims description 10
• 238000003745 diagnosis Methods 0.000 claims description 8
• 238000007917 intracranial administration Methods 0.000 claims description 7
• 238000007913 intrathecal administration Methods 0.000 claims description 7
• 108091032320 miR-146 stem-loop Proteins 0.000 claims description 7
• 108091024530 miR-146a stem-loop Proteins 0.000 claims description 7
• 201000008257 amyotrophic lateral sclerosis type 1 Diseases 0.000 claims description 6
• 239000012472 biological sample Substances 0.000 claims description 6
• 208000019995 familial amyotrophic lateral sclerosis Diseases 0.000 claims description 6
• 208000019929 sporadic amyotrophic lateral sclerosis Diseases 0.000 claims description 6
• 108091070404 miR-27b stem-loop Proteins 0.000 claims description 4
• 108091060293 miR-453 stem-loop Proteins 0.000 claims description 3
• 238000000746 purification Methods 0.000 claims description 3
• 208000034189 Sclerosis Diseases 0.000 claims 1
• 108091031103 miR-181a stem-loop Proteins 0.000 claims 1
• 108091046591 miR-181a-4 stem-loop Proteins 0.000 claims 1
• 108091049627 miR-181a-5 stem-loop Proteins 0.000 claims 1
• 108091037787 miR-19b stem-loop Proteins 0.000 claims 1
• 108091048101 miR-374b stem-loop Proteins 0.000 claims 1
• 108091056921 miR-532 stem-loop Proteins 0.000 claims 1
• 230000002757 inflammatory effect Effects 0.000 abstract description 172
• 201000006417 multiple sclerosis Diseases 0.000 abstract description 98
• 230000000694 effects Effects 0.000 abstract description 32
• 230000014509 gene expression Effects 0.000 description 140
• 108090000623 proteins and genes Proteins 0.000 description 127
• 108020004999 messenger RNA Proteins 0.000 description 56
• 230000009368 gene silencing by RNA Effects 0.000 description 52
• 241000699670 Mus sp. Species 0.000 description 51
• 230000003247 decreasing effect Effects 0.000 description 51
• 108091030071 RNAI Proteins 0.000 description 48
• 108010021188 Superoxide Dismutase-1 Proteins 0.000 description 46
• 102100038836 Superoxide dismutase [Cu-Zn] Human genes 0.000 description 46
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 45
• 239000000203 mixture Substances 0.000 description 44
• 230000001105 regulatory effect Effects 0.000 description 42
• 239000003550 marker Substances 0.000 description 41
• 201000010099 disease Diseases 0.000 description 39
• 102000004169 proteins and genes Human genes 0.000 description 34
• 210000004369 blood Anatomy 0.000 description 33
• 239000008280 blood Substances 0.000 description 33
• 239000004055 small Interfering RNA Substances 0.000 description 33
• 230000004048 modification Effects 0.000 description 32
• 238000012986 modification Methods 0.000 description 32
• 230000000692 anti-sense effect Effects 0.000 description 28
• 150000001875 compounds Chemical class 0.000 description 28
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 27
• 210000000274 microglia Anatomy 0.000 description 27
• 238000009472 formulation Methods 0.000 description 26
• 108020004459 Small interfering RNA Proteins 0.000 description 24
• 239000003795 chemical substances by application Substances 0.000 description 23
• 102100029722 Ectonucleoside triphosphate diphosphohydrolase 1 Human genes 0.000 description 22
• 101001012447 Homo sapiens Ectonucleoside triphosphate diphosphohydrolase 1 Proteins 0.000 description 22
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 22
• 230000009261 transgenic effect Effects 0.000 description 22
• 210000004027 cell Anatomy 0.000 description 21
• 230000002093 peripheral effect Effects 0.000 description 19
• 239000003814 drug Substances 0.000 description 17
• 230000004770 neurodegeneration Effects 0.000 description 17
• 238000002405 diagnostic procedure Methods 0.000 description 16
• 238000003753 real-time PCR Methods 0.000 description 16
• 238000000540 analysis of variance Methods 0.000 description 15
• 238000009396 hybridization Methods 0.000 description 15
• 238000003752 polymerase chain reaction Methods 0.000 description 15
• 239000011780 sodium chloride Substances 0.000 description 14
• 108020004414 DNA Proteins 0.000 description 13
• 108091033773 MiR-155 Proteins 0.000 description 13
• 238000010586 diagram Methods 0.000 description 13
• 239000008194 pharmaceutical composition Substances 0.000 description 13
• 235000000346 sugar Nutrition 0.000 description 13
• 238000004458 analytical method Methods 0.000 description 12
• 238000002474 experimental method Methods 0.000 description 12
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 11
• 102000040650 (ribonucleotides)n+m Human genes 0.000 description 11
• 108020000948 Antisense Oligonucleotides Proteins 0.000 description 11
• 206010061218 Inflammation Diseases 0.000 description 11
• 230000002452 interceptive effect Effects 0.000 description 11
• 239000001509 sodium citrate Substances 0.000 description 11
• 210000000278 spinal cord Anatomy 0.000 description 11
• 238000012360 testing method Methods 0.000 description 11
• HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 11
• 229940038773 trisodium citrate Drugs 0.000 description 11
• 239000013598 vector Substances 0.000 description 11
• ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 10
• 108091093037 Peptide nucleic acid Proteins 0.000 description 10
• 108091027967 Small hairpin RNA Proteins 0.000 description 10
• 239000013543 active substance Substances 0.000 description 10
• HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 10
• 238000003776 cleavage reaction Methods 0.000 description 10
• OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 10
• 230000004054 inflammatory process Effects 0.000 description 10
• RYVNIFSIEDRLSJ-UHFFFAOYSA-N 5-(hydroxymethyl)cytosine Chemical compound NC=1NC(=O)N=CC=1CO RYVNIFSIEDRLSJ-UHFFFAOYSA-N 0.000 description 9
• 108091032109 Homo sapiens miR-423 stem-loop Proteins 0.000 description 9
• 102100022338 Integrin alpha-M Human genes 0.000 description 9
• DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 9
• 230000027455 binding Effects 0.000 description 9
• 230000002074 deregulated effect Effects 0.000 description 9
• UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 9
• 230000007017 scission Effects 0.000 description 9
• CCEKAJIANROZEO-UHFFFAOYSA-N sulfluramid Chemical group CCNS(=O)(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F CCEKAJIANROZEO-UHFFFAOYSA-N 0.000 description 9
• 101001046686 Homo sapiens Integrin alpha-M Proteins 0.000 description 8
• 238000011831 SOD1-G93A transgenic mouse Methods 0.000 description 8
• 239000002253 acid Substances 0.000 description 8
• 229940079593 drug Drugs 0.000 description 8
• 230000006870 function Effects 0.000 description 8
• 230000036961 partial effect Effects 0.000 description 8
• 238000010149 post-hoc-test Methods 0.000 description 8
• 230000001225 therapeutic effect Effects 0.000 description 8
• RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 8
• 229930024421 Adenine Natural products 0.000 description 7
• 108091061783 Homo sapiens miR-598 stem-loop Proteins 0.000 description 7
• 108091028043 Nucleic acid sequence Proteins 0.000 description 7
• RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical class OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 7
• 229960000643 adenine Drugs 0.000 description 7
• 125000000217 alkyl group Chemical group 0.000 description 7
• 230000002255 enzymatic effect Effects 0.000 description 7
• 239000001257 hydrogen Substances 0.000 description 7
• 229910052739 hydrogen Inorganic materials 0.000 description 7
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 7
• 239000002105 nanoparticle Substances 0.000 description 7
• 229920001223 polyethylene glycol Polymers 0.000 description 7
• 238000002360 preparation method Methods 0.000 description 7
• 239000000243 solution Substances 0.000 description 7
• 210000000952 spleen Anatomy 0.000 description 7
• 239000013603 viral vector Substances 0.000 description 7
• 238000005406 washing Methods 0.000 description 7
• LRSASMSXMSNRBT-UHFFFAOYSA-N 5-methylcytosine Chemical compound CC1=CNC(=O)N=C1N LRSASMSXMSNRBT-UHFFFAOYSA-N 0.000 description 6
• GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 6
• 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 6
• 108091067572 Homo sapiens miR-221 stem-loop Proteins 0.000 description 6
• 108091067258 Homo sapiens miR-361 stem-loop Proteins 0.000 description 6
• 108091070377 Homo sapiens miR-93 stem-loop Proteins 0.000 description 6
• 108091007780 MiR-122 Proteins 0.000 description 6
• 208000012902 Nervous system disease Diseases 0.000 description 6
• 150000007513 acids Chemical class 0.000 description 6
• 230000037396 body weight Effects 0.000 description 6
• 235000012000 cholesterol Nutrition 0.000 description 6
• 208000035475 disorder Diseases 0.000 description 6
• 238000010195 expression analysis Methods 0.000 description 6
• 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 6
• 230000036541 health Effects 0.000 description 6
• 238000001802 infusion Methods 0.000 description 6
• 239000007788 liquid Substances 0.000 description 6
• 238000004519 manufacturing process Methods 0.000 description 6
• 108091051828 miR-122 stem-loop Proteins 0.000 description 6
• 238000012545 processing Methods 0.000 description 6
• 238000006467 substitution reaction Methods 0.000 description 6
• 239000000725 suspension Substances 0.000 description 6
• 108091069046 Homo sapiens let-7g stem-loop Proteins 0.000 description 5
• 108091069047 Homo sapiens let-7i stem-loop Proteins 0.000 description 5
• 108091060471 Homo sapiens miR-320c-1 stem-loop Proteins 0.000 description 5
• 108091078079 Homo sapiens miR-320c-2 stem-loop Proteins 0.000 description 5
• 108091067259 Homo sapiens miR-362 stem-loop Proteins 0.000 description 5
• 108091067545 Homo sapiens miR-383 stem-loop Proteins 0.000 description 5
• 108091092284 Homo sapiens miR-515-1 stem-loop Proteins 0.000 description 5
• 108091092278 Homo sapiens miR-515-2 stem-loop Proteins 0.000 description 5
• 108091061592 Homo sapiens miR-592 stem-loop Proteins 0.000 description 5
• 108091061625 Homo sapiens miR-640 stem-loop Proteins 0.000 description 5
• 108091061603 Homo sapiens miR-651 stem-loop Proteins 0.000 description 5
• 239000002202 Polyethylene glycol Substances 0.000 description 5
• 208000007400 Relapsing-Remitting Multiple Sclerosis Diseases 0.000 description 5
• 229930006000 Sucrose Natural products 0.000 description 5
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 5
• ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 5
• 229940104302 cytosine Drugs 0.000 description 5
• 235000014113 dietary fatty acids Nutrition 0.000 description 5
• 238000009826 distribution Methods 0.000 description 5
• 239000002552 dosage form Substances 0.000 description 5
• 239000000839 emulsion Substances 0.000 description 5
• 150000002148 esters Chemical class 0.000 description 5
• 239000000194 fatty acid Substances 0.000 description 5
• 229930195729 fatty acid Natural products 0.000 description 5
• 150000004665 fatty acids Chemical class 0.000 description 5
• 239000000463 material Substances 0.000 description 5
• 238000010172 mouse model Methods 0.000 description 5
• 239000002777 nucleoside Chemical class 0.000 description 5
• 230000000474 nursing effect Effects 0.000 description 5
• 239000000546 pharmaceutical excipient Substances 0.000 description 5
• 239000000843 powder Substances 0.000 description 5
• 239000003755 preservative agent Substances 0.000 description 5
• 150000003839 salts Chemical class 0.000 description 5
• 230000003393 splenic effect Effects 0.000 description 5
• 239000005720 sucrose Substances 0.000 description 5
• 239000003765 sweetening agent Substances 0.000 description 5
• 230000003827 upregulation Effects 0.000 description 5
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
• 238000009007 Diagnostic Kit Methods 0.000 description 4
• IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 4
• 101000625727 Homo sapiens Tubulin beta chain Proteins 0.000 description 4
• 108091070514 Homo sapiens let-7b stem-loop Proteins 0.000 description 4
• 108091044909 Homo sapiens miR-1206 stem-loop Proteins 0.000 description 4
• 108091051956 Homo sapiens miR-1537 stem-loop Proteins 0.000 description 4
• 108091069034 Homo sapiens miR-193a stem-loop Proteins 0.000 description 4
• 108091089962 Homo sapiens miR-2054 stem-loop Proteins 0.000 description 4
• 108091067552 Homo sapiens miR-379 stem-loop Proteins 0.000 description 4
• 108091092307 Homo sapiens miR-494 stem-loop Proteins 0.000 description 4
• 108091064366 Homo sapiens miR-513a-1 stem-loop Proteins 0.000 description 4
• 108091064370 Homo sapiens miR-513a-2 stem-loop Proteins 0.000 description 4
• 108091063808 Homo sapiens miR-574 stem-loop Proteins 0.000 description 4
• 108091061610 Homo sapiens miR-649 stem-loop Proteins 0.000 description 4
• 238000012228 RNA interference-mediated gene silencing Methods 0.000 description 4
• 238000011529 RT qPCR Methods 0.000 description 4
• 238000000692 Student's t-test Methods 0.000 description 4
• 102000009618 Transforming Growth Factors Human genes 0.000 description 4
• 102100024717 Tubulin beta chain Human genes 0.000 description 4
• 230000004913 activation Effects 0.000 description 4
• 150000001408 amides Chemical group 0.000 description 4
• 239000003086 colorant Substances 0.000 description 4
• 239000000796 flavoring agent Substances 0.000 description 4
• 235000003599 food sweetener Nutrition 0.000 description 4
• 239000000499 gel Substances 0.000 description 4
• FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 4
• 238000000338 in vitro Methods 0.000 description 4
• 150000002632 lipids Chemical class 0.000 description 4
• HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
• 108091053257 miR-99b stem-loop Proteins 0.000 description 4
• 238000010369 molecular cloning Methods 0.000 description 4
• 150000003833 nucleoside derivatives Chemical class 0.000 description 4
• 230000037361 pathway Effects 0.000 description 4
• 230000000770 proinflammatory effect Effects 0.000 description 4
• 239000002904 solvent Substances 0.000 description 4
• 238000012353 t test Methods 0.000 description 4
• 229940113082 thymine Drugs 0.000 description 4
• 229940035893 uracil Drugs 0.000 description 4
• OVONXEQGWXGFJD-UHFFFAOYSA-N 4-sulfanylidene-1h-pyrimidin-2-one Chemical compound SC=1C=CNC(=O)N=1 OVONXEQGWXGFJD-UHFFFAOYSA-N 0.000 description 3
• MSSXOMSJDRHRMC-UHFFFAOYSA-N 9H-purine-2,6-diamine Chemical compound NC1=NC(N)=C2NC=NC2=N1 MSSXOMSJDRHRMC-UHFFFAOYSA-N 0.000 description 3
• QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
• 208000024827 Alzheimer disease Diseases 0.000 description 3
• 241000416162 Astragalus gummifer Species 0.000 description 3
• 108091032955 Bacterial small RNA Proteins 0.000 description 3
• 102100026031 Beta-glucuronidase Human genes 0.000 description 3
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
• 101000933465 Homo sapiens Beta-glucuronidase Proteins 0.000 description 3
• 108091069017 Homo sapiens miR-140 stem-loop Proteins 0.000 description 3
• 108091067982 Homo sapiens miR-197 stem-loop Proteins 0.000 description 3
• 108091067253 Homo sapiens miR-369 stem-loop Proteins 0.000 description 3
• 108091092306 Homo sapiens miR-432 stem-loop Proteins 0.000 description 3
• 108091061672 Homo sapiens miR-660 stem-loop Proteins 0.000 description 3
• 108091086460 Homo sapiens miR-708 stem-loop Proteins 0.000 description 3
• 208000023105 Huntington disease Diseases 0.000 description 3
• 241000124008 Mammalia Species 0.000 description 3
• 241001465754 Metazoa Species 0.000 description 3
• 241000699666 Mus <mouse, genus> Species 0.000 description 3
• 208000018737 Parkinson disease Diseases 0.000 description 3
• 239000004952 Polyamide Substances 0.000 description 3
• 229920002873 Polyethylenimine Polymers 0.000 description 3
• 241000288906 Primates Species 0.000 description 3
• 230000007022 RNA scission Effects 0.000 description 3
• FTALBRSUTCGOEG-UHFFFAOYSA-N Riluzole Chemical compound C1=C(OC(F)(F)F)C=C2SC(N)=NC2=C1 FTALBRSUTCGOEG-UHFFFAOYSA-N 0.000 description 3
• 229920001615 Tragacanth Polymers 0.000 description 3
• 239000000443 aerosol Substances 0.000 description 3
• 239000007900 aqueous suspension Substances 0.000 description 3
• 238000003491 array Methods 0.000 description 3
• 210000004556 brain Anatomy 0.000 description 3
• 230000001413 cellular effect Effects 0.000 description 3
• 238000006243 chemical reaction Methods 0.000 description 3
• 239000007859 condensation product Substances 0.000 description 3
• 125000000753 cycloalkyl group Chemical group 0.000 description 3
• 238000007405 data analysis Methods 0.000 description 3
• 238000011161 development Methods 0.000 description 3
• 239000003937 drug carrier Substances 0.000 description 3
• 239000003995 emulsifying agent Substances 0.000 description 3
• 238000001943 fluorescence-activated cell sorting Methods 0.000 description 3
• 235000013355 food flavoring agent Nutrition 0.000 description 3
• 230000005764 inhibitory process Effects 0.000 description 3
• 238000003780 insertion Methods 0.000 description 3
• 230000037431 insertion Effects 0.000 description 3
• 230000003993 interaction Effects 0.000 description 3
• 238000002372 labelling Methods 0.000 description 3
• 230000000670 limiting effect Effects 0.000 description 3
• 239000002502 liposome Substances 0.000 description 3
• 230000001404 mediated effect Effects 0.000 description 3
• 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 3
• 239000004005 microsphere Substances 0.000 description 3
• 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 3
• 210000003205 muscle Anatomy 0.000 description 3
• 231100000252 nontoxic Toxicity 0.000 description 3
• 230000003000 nontoxic effect Effects 0.000 description 3
• 239000003921 oil Substances 0.000 description 3
• 235000019198 oils Nutrition 0.000 description 3
• 210000000056 organ Anatomy 0.000 description 3
• 210000005259 peripheral blood Anatomy 0.000 description 3
• 239000011886 peripheral blood Substances 0.000 description 3
• 230000003285 pharmacodynamic effect Effects 0.000 description 3
• 150000003904 phospholipids Chemical class 0.000 description 3
• 210000002381 plasma Anatomy 0.000 description 3
• 229920002647 polyamide Polymers 0.000 description 3
• 229920000768 polyamine Polymers 0.000 description 3
• 102000040430 polynucleotide Human genes 0.000 description 3
• 108091033319 polynucleotide Proteins 0.000 description 3
• 239000002157 polynucleotide Substances 0.000 description 3
• 230000001124 posttranscriptional effect Effects 0.000 description 3
• 238000000513 principal component analysis Methods 0.000 description 3
• 230000000750 progressive effect Effects 0.000 description 3
• 238000011160 research Methods 0.000 description 3
• 239000003826 tablet Substances 0.000 description 3
• 230000008685 targeting Effects 0.000 description 3
• RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 3
• 210000001519 tissue Anatomy 0.000 description 3
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
• 230000004580 weight loss Effects 0.000 description 3
• 239000000080 wetting agent Substances 0.000 description 3
• PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
• LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 2
• BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 2
• QGVQZRDQPDLHHV-DPAQBDIFSA-N (3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthrene-3-thiol Chemical compound C1C=C2C[C@@H](S)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 QGVQZRDQPDLHHV-DPAQBDIFSA-N 0.000 description 2
• QYAPHLRPFNSDNH-MRFRVZCGSA-N (4s,4as,5as,6s,12ar)-7-chloro-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride Chemical compound Cl.C1=CC(Cl)=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O QYAPHLRPFNSDNH-MRFRVZCGSA-N 0.000 description 2
• ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 2
• IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 2
• KSXTUUUQYQYKCR-LQDDAWAPSA-M 2,3-bis[[(z)-octadec-9-enoyl]oxy]propyl-trimethylazanium;chloride Chemical compound [Cl-].CCCCCCCC\C=C/CCCCCCCC(=O)OCC(C[N+](C)(C)C)OC(=O)CCCCCCC\C=C/CCCCCCCC KSXTUUUQYQYKCR-LQDDAWAPSA-M 0.000 description 2
• FZWGECJQACGGTI-UHFFFAOYSA-N 2-amino-7-methyl-1,7-dihydro-6H-purin-6-one Chemical compound NC1=NC(O)=C2N(C)C=NC2=N1 FZWGECJQACGGTI-UHFFFAOYSA-N 0.000 description 2
• UJCKLFHNYNJNPS-AUYXYSRISA-N 4-[(9z,28z)-heptatriaconta-9,28-dien-19-yl]-1-methylpyridin-1-ium Chemical compound CCCCCCCC\C=C/CCCCCCCCC(CCCCCCCC\C=C/CCCCCCCC)C1=CC=[N+](C)C=C1 UJCKLFHNYNJNPS-AUYXYSRISA-N 0.000 description 2
• ZLAQATDNGLKIEV-UHFFFAOYSA-N 5-methyl-2-sulfanylidene-1h-pyrimidin-4-one Chemical compound CC1=CNC(=S)NC1=O ZLAQATDNGLKIEV-UHFFFAOYSA-N 0.000 description 2
• UJBCLAXPPIDQEE-UHFFFAOYSA-N 5-prop-1-ynyl-1h-pyrimidine-2,4-dione Chemical compound CC#CC1=CNC(=O)NC1=O UJBCLAXPPIDQEE-UHFFFAOYSA-N 0.000 description 2
• 102100021206 60S ribosomal protein L19 Human genes 0.000 description 2
• PEHVGBZKEYRQSX-UHFFFAOYSA-N 7-deaza-adenine Chemical compound NC1=NC=NC2=C1C=CN2 PEHVGBZKEYRQSX-UHFFFAOYSA-N 0.000 description 2
• LOSIULRWFAEMFL-UHFFFAOYSA-N 7-deazaguanine Chemical compound O=C1NC(N)=NC2=C1CC=N2 LOSIULRWFAEMFL-UHFFFAOYSA-N 0.000 description 2
• HCGHYQLFMPXSDU-UHFFFAOYSA-N 7-methyladenine Chemical compound C1=NC(N)=C2N(C)C=NC2=N1 HCGHYQLFMPXSDU-UHFFFAOYSA-N 0.000 description 2
• KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
• LPXQRXLUHJKZIE-UHFFFAOYSA-N 8-azaguanine Chemical compound NC1=NC(O)=C2NN=NC2=N1 LPXQRXLUHJKZIE-UHFFFAOYSA-N 0.000 description 2
• 229960005508 8-azaguanine Drugs 0.000 description 2
• LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
• 244000215068 Acacia senegal Species 0.000 description 2
• 235000006491 Acacia senegal Nutrition 0.000 description 2
• CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
• 206010003591 Ataxia Diseases 0.000 description 2
• 102100027314 Beta-2-microglobulin Human genes 0.000 description 2
• 102100031650 C-X-C chemokine receptor type 4 Human genes 0.000 description 2
• 239000004380 Cholic acid Substances 0.000 description 2
• 102100026127 Clathrin heavy chain 1 Human genes 0.000 description 2
• 102100026359 Cyclic AMP-responsive element-binding protein 1 Human genes 0.000 description 2
• FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
• FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
• FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
• 102000053602 DNA Human genes 0.000 description 2
• 241000196324 Embryophyta Species 0.000 description 2
• 102000004190 Enzymes Human genes 0.000 description 2
• 108090000790 Enzymes Proteins 0.000 description 2
• 108700039887 Essential Genes Proteins 0.000 description 2
• 102100033067 Growth factor receptor-bound protein 2 Human genes 0.000 description 2
• 229920000084 Gum arabic Polymers 0.000 description 2
• 101001105789 Homo sapiens 60S ribosomal protein L19 Proteins 0.000 description 2
• 101000756632 Homo sapiens Actin, cytoplasmic 1 Proteins 0.000 description 2
• 101000937544 Homo sapiens Beta-2-microglobulin Proteins 0.000 description 2
• 101000922348 Homo sapiens C-X-C chemokine receptor type 4 Proteins 0.000 description 2
• 101000912851 Homo sapiens Clathrin heavy chain 1 Proteins 0.000 description 2
• 101000855516 Homo sapiens Cyclic AMP-responsive element-binding protein 1 Proteins 0.000 description 2
• 101000907904 Homo sapiens Endoribonuclease Dicer Proteins 0.000 description 2
• 101000896557 Homo sapiens Eukaryotic translation initiation factor 3 subunit B Proteins 0.000 description 2
• 101000871017 Homo sapiens Growth factor receptor-bound protein 2 Proteins 0.000 description 2
• 101000988834 Homo sapiens Hypoxanthine-guanine phosphoribosyltransferase Proteins 0.000 description 2
• 101000579123 Homo sapiens Phosphoglycerate kinase 1 Proteins 0.000 description 2
• 101000788517 Homo sapiens Tubulin beta-2A chain Proteins 0.000 description 2
• 108091069089 Homo sapiens miR-146a stem-loop Proteins 0.000 description 2
• 108091068998 Homo sapiens miR-191 stem-loop Proteins 0.000 description 2
• 108091069018 Homo sapiens miR-27b stem-loop Proteins 0.000 description 2
• 108091065457 Homo sapiens miR-99b stem-loop Proteins 0.000 description 2
• UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
• UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 2
• 102100029098 Hypoxanthine-guanine phosphoribosyltransferase Human genes 0.000 description 2
• 108010021625 Immunoglobulin Fragments Proteins 0.000 description 2
• 102000008394 Immunoglobulin Fragments Human genes 0.000 description 2
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
• 241000713666 Lentivirus Species 0.000 description 2
• 108010018650 MEF2 Transcription Factors Proteins 0.000 description 2
• 108091007424 MIR27B Proteins 0.000 description 2
• 229930195725 Mannitol Natural products 0.000 description 2
• 108091028080 MiR-132 Proteins 0.000 description 2
• HSHXDCVZWHOWCS-UHFFFAOYSA-N N'-hexadecylthiophene-2-carbohydrazide Chemical compound CCCCCCCCCCCCCCCCNNC(=O)c1cccs1 HSHXDCVZWHOWCS-UHFFFAOYSA-N 0.000 description 2
• 101710163270 Nuclease Proteins 0.000 description 2
• REYJJPSVUYRZGE-UHFFFAOYSA-N Octadecylamine Chemical compound CCCCCCCCCCCCCCCCCCN REYJJPSVUYRZGE-UHFFFAOYSA-N 0.000 description 2
• KJWZYMMLVHIVSU-IYCNHOCDSA-N PGK1 Chemical compound CCCCC[C@H](O)\C=C\[C@@H]1[C@@H](CCCCCCC(O)=O)C(=O)CC1=O KJWZYMMLVHIVSU-IYCNHOCDSA-N 0.000 description 2
• 102100028251 Phosphoglycerate kinase 1 Human genes 0.000 description 2
• WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
• 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 2
• 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 2
• 208000007014 Retinitis pigmentosa Diseases 0.000 description 2
• 108010057163 Ribonuclease III Proteins 0.000 description 2
• 102000003661 Ribonuclease III Human genes 0.000 description 2
• 241000283984 Rodentia Species 0.000 description 2
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
• 108091081021 Sense strand Proteins 0.000 description 2
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
• 101710202373 Specificity protein transcription factor 1 Proteins 0.000 description 2
• 229920002472 Starch Polymers 0.000 description 2
• 241000700605 Viruses Species 0.000 description 2
• 235000010489 acacia gum Nutrition 0.000 description 2
• DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
• DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 2
• 239000004480 active ingredient Substances 0.000 description 2
• ORILYTVJVMAKLC-UHFFFAOYSA-N adamantane Chemical compound C1C(C2)CC3CC1CC2C3 ORILYTVJVMAKLC-UHFFFAOYSA-N 0.000 description 2
• 238000007792 addition Methods 0.000 description 2
• 206010064930 age-related macular degeneration Diseases 0.000 description 2
• 125000001931 aliphatic group Chemical group 0.000 description 2
• 238000010171 animal model Methods 0.000 description 2
• 239000003963 antioxidant agent Substances 0.000 description 2
• 235000006708 antioxidants Nutrition 0.000 description 2
• 238000013459 approach Methods 0.000 description 2
• 230000001580 bacterial effect Effects 0.000 description 2
• 230000037429 base substitution Effects 0.000 description 2
• 230000008901 benefit Effects 0.000 description 2
• 239000011230 binding agent Substances 0.000 description 2
• 229960002685 biotin Drugs 0.000 description 2
• 235000020958 biotin Nutrition 0.000 description 2
• 239000011616 biotin Substances 0.000 description 2
• 239000002775 capsule Substances 0.000 description 2
• 239000001768 carboxy methyl cellulose Substances 0.000 description 2
• 239000012876 carrier material Substances 0.000 description 2
• 230000015556 catabolic process Effects 0.000 description 2
• 230000003197 catalytic effect Effects 0.000 description 2
• 150000001768 cations Chemical class 0.000 description 2
• 230000004700 cellular uptake Effects 0.000 description 2
• 230000035605 chemotaxis Effects 0.000 description 2
• 235000019416 cholic acid Nutrition 0.000 description 2
• BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 2
• 229960002471 cholic acid Drugs 0.000 description 2
• 230000000052 comparative effect Effects 0.000 description 2
• 239000003184 complementary RNA Substances 0.000 description 2
• 238000009833 condensation Methods 0.000 description 2
• 230000005494 condensation Effects 0.000 description 2
• 239000006071 cream Substances 0.000 description 2
• 238000006731 degradation reaction Methods 0.000 description 2
• 238000012217 deletion Methods 0.000 description 2
• 230000037430 deletion Effects 0.000 description 2
• KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 2
• 238000013461 design Methods 0.000 description 2
• 230000029087 digestion Effects 0.000 description 2
• 239000003085 diluting agent Substances 0.000 description 2
• 239000002270 dispersing agent Substances 0.000 description 2
• 230000003828 downregulation Effects 0.000 description 2
• 239000008298 dragée Substances 0.000 description 2
• 230000008482 dysregulation Effects 0.000 description 2
• 238000005516 engineering process Methods 0.000 description 2
• 230000002708 enhancing effect Effects 0.000 description 2
• 239000000945 filler Substances 0.000 description 2
• 239000012530 fluid Substances 0.000 description 2
• 230000037406 food intake Effects 0.000 description 2
• 125000003827 glycol group Chemical group 0.000 description 2
• 125000001475 halogen functional group Chemical group 0.000 description 2
• 125000005842 heteroatom Chemical group 0.000 description 2
• 125000000623 heterocyclic group Chemical group 0.000 description 2
• BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
• 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
• 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
• 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
• 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
• 238000001727 in vivo Methods 0.000 description 2
• 230000028709 inflammatory response Effects 0.000 description 2
• 238000001990 intravenous administration Methods 0.000 description 2
• 239000008101 lactose Substances 0.000 description 2
• 108091091807 let-7a stem-loop Proteins 0.000 description 2
• 108091057746 let-7a-4 stem-loop Proteins 0.000 description 2
• 108091028376 let-7a-5 stem-loop Proteins 0.000 description 2
• 108091024393 let-7a-6 stem-loop Proteins 0.000 description 2
• 108091091174 let-7a-7 stem-loop Proteins 0.000 description 2
• 229940057995 liquid paraffin Drugs 0.000 description 2
• 230000033001 locomotion Effects 0.000 description 2
• 239000000314 lubricant Substances 0.000 description 2
• 208000002780 macular degeneration Diseases 0.000 description 2
• 235000019359 magnesium stearate Nutrition 0.000 description 2
• 239000000594 mannitol Substances 0.000 description 2
• 235000010355 mannitol Nutrition 0.000 description 2
• 230000004060 metabolic process Effects 0.000 description 2
• MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 2
• 229920000609 methyl cellulose Polymers 0.000 description 2
• 235000010981 methylcellulose Nutrition 0.000 description 2
• 239000001923 methylcellulose Substances 0.000 description 2
• YACKEPLHDIMKIO-UHFFFAOYSA-N methylphosphonic acid Chemical class CP(O)(O)=O YACKEPLHDIMKIO-UHFFFAOYSA-N 0.000 description 2
• 108091050874 miR-19a stem-loop Proteins 0.000 description 2
• 108091086850 miR-19a-1 stem-loop Proteins 0.000 description 2
• 108091088468 miR-19a-2 stem-loop Proteins 0.000 description 2
• 108091083275 miR-26b stem-loop Proteins 0.000 description 2
• 108091029119 miR-34a stem-loop Proteins 0.000 description 2
• 238000003253 miRNA assay Methods 0.000 description 2
• 239000002480 mineral oil Substances 0.000 description 2
• 235000010446 mineral oil Nutrition 0.000 description 2
• 230000035772 mutation Effects 0.000 description 2
• 238000003012 network analysis Methods 0.000 description 2
• 230000000626 neurodegenerative effect Effects 0.000 description 2
• 230000000926 neurological effect Effects 0.000 description 2
• 230000016273 neuron death Effects 0.000 description 2
• 125000004433 nitrogen atom Chemical group N* 0.000 description 2
• 239000000346 nonvolatile oil Substances 0.000 description 2
• 125000003835 nucleoside group Chemical group 0.000 description 2
• 238000001543 one-way ANOVA Methods 0.000 description 2
• 229910052760 oxygen Inorganic materials 0.000 description 2
• 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
• 208000035824 paresthesia Diseases 0.000 description 2
• 239000006072 paste Substances 0.000 description 2
• 230000008506 pathogenesis Effects 0.000 description 2
• 238000003068 pathway analysis Methods 0.000 description 2
• ONTNXMBMXUNDBF-UHFFFAOYSA-N pentatriacontane-17,18,19-triol Chemical compound CCCCCCCCCCCCCCCCC(O)C(O)C(O)CCCCCCCCCCCCCCCC ONTNXMBMXUNDBF-UHFFFAOYSA-N 0.000 description 2
• RDOWQLZANAYVLL-UHFFFAOYSA-N phenanthridine Chemical compound C1=CC=C2C3=CC=CC=C3C=NC2=C1 RDOWQLZANAYVLL-UHFFFAOYSA-N 0.000 description 2
• 229910052698 phosphorus Inorganic materials 0.000 description 2
• 230000004962 physiological condition Effects 0.000 description 2
• 239000006187 pill Substances 0.000 description 2
• 239000013612 plasmid Substances 0.000 description 2
• 229920000729 poly(L-lysine) polymer Polymers 0.000 description 2
• 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
• 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 2
• 229920000053 polysorbate 80 Polymers 0.000 description 2
• 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
• 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
• 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
• 239000000047 product Substances 0.000 description 2
• QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
• 150000003230 pyrimidines Chemical class 0.000 description 2
• 102000005962 receptors Human genes 0.000 description 2
• 108020003175 receptors Proteins 0.000 description 2
• 230000000717 retained effect Effects 0.000 description 2
• 125000002652 ribonucleotide group Chemical group 0.000 description 2
• 125000000548 ribosyl group Chemical group C1([C@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 2
• 229960004181 riluzole Drugs 0.000 description 2
• 229920002477 rna polymer Polymers 0.000 description 2
• 235000010413 sodium alginate Nutrition 0.000 description 2
• 239000000661 sodium alginate Substances 0.000 description 2
• 229940005550 sodium alginate Drugs 0.000 description 2
• 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
• 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
• 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
• 239000007787 solid Substances 0.000 description 2
• 239000012439 solid excipient Substances 0.000 description 2
• 239000000600 sorbitol Substances 0.000 description 2
• 230000009870 specific binding Effects 0.000 description 2
• 239000007921 spray Substances 0.000 description 2
• 239000003381 stabilizer Substances 0.000 description 2
• 235000019698 starch Nutrition 0.000 description 2
• 150000003431 steroids Chemical class 0.000 description 2
• 239000000126 substance Substances 0.000 description 2
• 239000000758 substrate Substances 0.000 description 2
• 239000000829 suppository Substances 0.000 description 2
• 239000000375 suspending agent Substances 0.000 description 2
• 239000006188 syrup Substances 0.000 description 2
• 235000020357 syrup Nutrition 0.000 description 2
• 229940124597 therapeutic agent Drugs 0.000 description 2
• 150000003568 thioethers Chemical class 0.000 description 2
• 230000000451 tissue damage Effects 0.000 description 2
• 231100000827 tissue damage Toxicity 0.000 description 2
• 230000000699 topical effect Effects 0.000 description 2
• 231100000419 toxicity Toxicity 0.000 description 2
• 230000001988 toxicity Effects 0.000 description 2
• 238000013518 transcription Methods 0.000 description 2
• 230000035897 transcription Effects 0.000 description 2
• 230000002103 transcriptional effect Effects 0.000 description 2
• ZMANZCXQSJIPKH-UHFFFAOYSA-O triethylammonium ion Chemical compound CC[NH+](CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-O 0.000 description 2
• 241001430294 unidentified retrovirus Species 0.000 description 2
• 235000015112 vegetable and seed oil Nutrition 0.000 description 2
• 239000008158 vegetable oil Substances 0.000 description 2
• 239000003981 vehicle Substances 0.000 description 2
• 238000012795 verification Methods 0.000 description 2
• 239000000341 volatile oil Substances 0.000 description 2
• 238000009736 wetting Methods 0.000 description 2
• HDTRYLNUVZCQOY-UHFFFAOYSA-N &alpha;-D-glucopyranosyl-&alpha;-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
• HRJXKKSJPNWKCP-UNXDAHLPSA-N (1E,2Z)-3-hydroxy-5,9,17-trioxo-4,5:9,10-disecoandrosta-1(10),2-dien-4-oic acid Chemical compound C1CC(=O)[C@@H](CCC(=O)C(=C/C=C(\O)C(O)=O)/C)[C@@H]2CCC(=O)[C@]21C HRJXKKSJPNWKCP-UNXDAHLPSA-N 0.000 description 1
• JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
• YLOCGHYTXIINAI-XKUOMLDTSA-N (2s)-2-amino-3-(4-hydroxyphenyl)propanoic acid;(2s)-2-aminopentanedioic acid;(2s)-2-aminopropanoic acid;(2s)-2,6-diaminohexanoic acid Chemical compound C[C@H](N)C(O)=O.NCCCC[C@H](N)C(O)=O.OC(=O)[C@@H](N)CCC(O)=O.OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 YLOCGHYTXIINAI-XKUOMLDTSA-N 0.000 description 1
• WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
• DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
• FYADHXFMURLYQI-UHFFFAOYSA-N 1,2,4-triazine Chemical class C1=CN=NC=N1 FYADHXFMURLYQI-UHFFFAOYSA-N 0.000 description 1
• PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 description 1
• IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
• 102100030390 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 Human genes 0.000 description 1
• UHUHBFMZVCOEOV-UHFFFAOYSA-N 1h-imidazo[4,5-c]pyridin-4-amine Chemical compound NC1=NC=CC2=C1N=CN2 UHUHBFMZVCOEOV-UHFFFAOYSA-N 0.000 description 1
• VEPOHXYIFQMVHW-XOZOLZJESA-N 2,3-dihydroxybutanedioic acid (2S,3S)-3,4-dimethyl-2-phenylmorpholine Chemical compound OC(C(O)C(O)=O)C(O)=O.C[C@H]1[C@@H](OCCN1C)c1ccccc1 VEPOHXYIFQMVHW-XOZOLZJESA-N 0.000 description 1
• QSHACTSJHMKXTE-UHFFFAOYSA-N 2-(2-aminopropyl)-7h-purin-6-amine Chemical compound CC(N)CC1=NC(N)=C2NC=NC2=N1 QSHACTSJHMKXTE-UHFFFAOYSA-N 0.000 description 1
• PIINGYXNCHTJTF-UHFFFAOYSA-N 2-(2-azaniumylethylamino)acetate Chemical group NCCNCC(O)=O PIINGYXNCHTJTF-UHFFFAOYSA-N 0.000 description 1
• AQQSXKSWTNWXKR-UHFFFAOYSA-N 2-(2-phenylphenanthro[9,10-d]imidazol-3-yl)acetic acid Chemical compound C1(=CC=CC=C1)C1=NC2=C(N1CC(=O)O)C1=CC=CC=C1C=1C=CC=CC=12 AQQSXKSWTNWXKR-UHFFFAOYSA-N 0.000 description 1
• LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
• OALHHIHQOFIMEF-UHFFFAOYSA-N 3',6'-dihydroxy-2',4',5',7'-tetraiodo-3h-spiro[2-benzofuran-1,9'-xanthene]-3-one Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(I)=C(O)C(I)=C1OC1=C(I)C(O)=C(I)C=C21 OALHHIHQOFIMEF-UHFFFAOYSA-N 0.000 description 1
• CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
• 229960000549 4-dimethylaminophenol Drugs 0.000 description 1
• VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-dimethylaminopyridine Substances CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 1
• 102100030755 5-aminolevulinate synthase, nonspecific, mitochondrial Human genes 0.000 description 1
• LQLQRFGHAALLLE-UHFFFAOYSA-N 5-bromouracil Chemical compound BrC1=CNC(=O)NC1=O LQLQRFGHAALLLE-UHFFFAOYSA-N 0.000 description 1
• JDBGXEHEIRGOBU-UHFFFAOYSA-N 5-hydroxymethyluracil Chemical compound OCC1=CNC(=O)NC1=O JDBGXEHEIRGOBU-UHFFFAOYSA-N 0.000 description 1
• KXBCLNRMQPRVTP-UHFFFAOYSA-N 6-amino-1,5-dihydroimidazo[4,5-c]pyridin-4-one Chemical compound O=C1NC(N)=CC2=C1N=CN2 KXBCLNRMQPRVTP-UHFFFAOYSA-N 0.000 description 1
• DCPSTSVLRXOYGS-UHFFFAOYSA-N 6-amino-1h-pyrimidine-2-thione Chemical compound NC1=CC=NC(S)=N1 DCPSTSVLRXOYGS-UHFFFAOYSA-N 0.000 description 1
• QNNARSZPGNJZIX-UHFFFAOYSA-N 6-amino-5-prop-1-ynyl-1h-pyrimidin-2-one Chemical compound CC#CC1=CNC(=O)N=C1N QNNARSZPGNJZIX-UHFFFAOYSA-N 0.000 description 1
• CKOMXBHMKXXTNW-UHFFFAOYSA-N 6-methyladenine Chemical compound CNC1=NC=NC2=C1N=CN2 CKOMXBHMKXXTNW-UHFFFAOYSA-N 0.000 description 1
• 102100040881 60S acidic ribosomal protein P0 Human genes 0.000 description 1
• 102100021546 60S ribosomal protein L10 Human genes 0.000 description 1
• HRYKDUPGBWLLHO-UHFFFAOYSA-N 8-azaadenine Chemical compound NC1=NC=NC2=NNN=C12 HRYKDUPGBWLLHO-UHFFFAOYSA-N 0.000 description 1
• QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
• 102100020979 ATP-binding cassette sub-family F member 1 Human genes 0.000 description 1
• 208000035657 Abasia Diseases 0.000 description 1
• 229920001817 Agar Polymers 0.000 description 1
• GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
• 241000710929 Alphavirus Species 0.000 description 1
• 208000000044 Amnesia Diseases 0.000 description 1
• 108020004491 Antisense DNA Proteins 0.000 description 1
• 108020005544 Antisense RNA Proteins 0.000 description 1
• 208000019901 Anxiety disease Diseases 0.000 description 1
• 108010011485 Aspartame Proteins 0.000 description 1
• 241000972773 Aulopiformes Species 0.000 description 1
• 108090001008 Avidin Proteins 0.000 description 1
• 108700009171 B-Cell Lymphoma 3 Proteins 0.000 description 1
• 102100021570 B-cell lymphoma 3 protein Human genes 0.000 description 1
• 102100021631 B-cell lymphoma 6 protein Human genes 0.000 description 1
• 101150072667 Bcl3 gene Proteins 0.000 description 1
• 201000004569 Blindness Diseases 0.000 description 1
• 239000004604 Blowing Agent Substances 0.000 description 1
• 206010006100 Bradykinesia Diseases 0.000 description 1
• 208000003174 Brain Neoplasms Diseases 0.000 description 1
• 102100031172 C-C chemokine receptor type 1 Human genes 0.000 description 1
• 101710149814 C-C chemokine receptor type 1 Proteins 0.000 description 1
• 102100031151 C-C chemokine receptor type 2 Human genes 0.000 description 1
• 101710149815 C-C chemokine receptor type 2 Proteins 0.000 description 1
• 102100032367 C-C motif chemokine 5 Human genes 0.000 description 1
• 102100036189 C-X-C motif chemokine 3 Human genes 0.000 description 1
• 108010017009 CD11b Antigen Proteins 0.000 description 1
• 101150066577 CD14 gene Proteins 0.000 description 1
• 102100032912 CD44 antigen Human genes 0.000 description 1
• 102100027221 CD81 antigen Human genes 0.000 description 1
• 102100027217 CD82 antigen Human genes 0.000 description 1
• 102100035793 CD83 antigen Human genes 0.000 description 1
• QCMYYKRYFNMIEC-UHFFFAOYSA-N COP(O)=O Chemical class COP(O)=O QCMYYKRYFNMIEC-UHFFFAOYSA-N 0.000 description 1
• 108091011896 CSF1 Proteins 0.000 description 1
• UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
• 102000011068 Cdc42 Human genes 0.000 description 1
• 241000238366 Cephalopoda Species 0.000 description 1
• 206010008748 Chorea Diseases 0.000 description 1
• 206010009696 Clumsiness Diseases 0.000 description 1
• 108091026890 Coding region Proteins 0.000 description 1
• 102000008186 Collagen Human genes 0.000 description 1
• 108010035532 Collagen Proteins 0.000 description 1
• VPAXJOUATWLOPR-UHFFFAOYSA-N Conferone Chemical compound C1=CC(=O)OC2=CC(OCC3C4(C)CCC(=O)C(C)(C)C4CC=C3C)=CC=C21 VPAXJOUATWLOPR-UHFFFAOYSA-N 0.000 description 1
• 108010043471 Core Binding Factor Alpha 2 Subunit Proteins 0.000 description 1
• 102100023033 Cyclic AMP-dependent transcription factor ATF-2 Human genes 0.000 description 1
• 108010016788 Cyclin-Dependent Kinase Inhibitor p21 Proteins 0.000 description 1
• 102100033270 Cyclin-dependent kinase inhibitor 1 Human genes 0.000 description 1
• 108010037462 Cyclooxygenase 2 Proteins 0.000 description 1
• HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
• 102100029145 DNA damage-inducible transcript 3 protein Human genes 0.000 description 1
• 230000004543 DNA replication Effects 0.000 description 1
• 238000001712 DNA sequencing Methods 0.000 description 1
• 102100027700 DNA-directed RNA polymerase I subunit RPA2 Human genes 0.000 description 1
• 102100021429 DNA-directed RNA polymerase II subunit RPB1 Human genes 0.000 description 1
• 101100457345 Danio rerio mapk14a gene Proteins 0.000 description 1
• 101100457347 Danio rerio mapk14b gene Proteins 0.000 description 1
• 241000702421 Dependoparvovirus Species 0.000 description 1
• 208000003164 Diplopia Diseases 0.000 description 1
• 102100023401 Dual specificity mitogen-activated protein kinase kinase 6 Human genes 0.000 description 1
• 206010013975 Dyspnoeas Diseases 0.000 description 1
• 208000014094 Dystonic disease Diseases 0.000 description 1
• 102100023362 Elongation factor 1-gamma Human genes 0.000 description 1
• 101710191461 F420-dependent glucose-6-phosphate dehydrogenase Proteins 0.000 description 1
• 108010010803 Gelatin Proteins 0.000 description 1
• 108010072051 Glatiramer Acetate Proteins 0.000 description 1
• 102100033417 Glucocorticoid receptor Human genes 0.000 description 1
• 101710155861 Glucose-6-phosphate 1-dehydrogenase Proteins 0.000 description 1
• 102100035172 Glucose-6-phosphate 1-dehydrogenase Human genes 0.000 description 1
• 101710174622 Glucose-6-phosphate 1-dehydrogenase, chloroplastic Proteins 0.000 description 1
• 101710137456 Glucose-6-phosphate 1-dehydrogenase, cytoplasmic isoform Proteins 0.000 description 1
• 102100035354 Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 Human genes 0.000 description 1
• 102100025334 Guanine nucleotide-binding protein G(q) subunit alpha Human genes 0.000 description 1
• 102100032610 Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas Human genes 0.000 description 1
• 102100040505 HLA class II histocompatibility antigen, DR alpha chain Human genes 0.000 description 1
• 108010067802 HLA-DR alpha-Chains Proteins 0.000 description 1
• 108090001102 Hammerhead ribozyme Proteins 0.000 description 1
• 241000238631 Hexapoda Species 0.000 description 1
• 102100038006 High affinity immunoglobulin epsilon receptor subunit alpha Human genes 0.000 description 1
• 102100022132 High affinity immunoglobulin epsilon receptor subunit gamma Human genes 0.000 description 1
• 241000282412 Homo Species 0.000 description 1
• 101000583063 Homo sapiens 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 Proteins 0.000 description 1
• 101000843649 Homo sapiens 5-aminolevulinate synthase, nonspecific, mitochondrial Proteins 0.000 description 1
• 101000673456 Homo sapiens 60S acidic ribosomal protein P0 Proteins 0.000 description 1
• 101001108634 Homo sapiens 60S ribosomal protein L10 Proteins 0.000 description 1
• 101001117935 Homo sapiens 60S ribosomal protein L15 Proteins 0.000 description 1
• 101000783783 Homo sapiens ATP-binding cassette sub-family F member 1 Proteins 0.000 description 1
• 101000971234 Homo sapiens B-cell lymphoma 6 protein Proteins 0.000 description 1
• 101000797762 Homo sapiens C-C motif chemokine 5 Proteins 0.000 description 1
• 101000947193 Homo sapiens C-X-C motif chemokine 3 Proteins 0.000 description 1
• 101000868273 Homo sapiens CD44 antigen Proteins 0.000 description 1
• 101000914479 Homo sapiens CD81 antigen Proteins 0.000 description 1
• 101000914469 Homo sapiens CD82 antigen Proteins 0.000 description 1
• 101000946856 Homo sapiens CD83 antigen Proteins 0.000 description 1
• 101000983518 Homo sapiens Caspase-10 Proteins 0.000 description 1
• 101000974934 Homo sapiens Cyclic AMP-dependent transcription factor ATF-2 Proteins 0.000 description 1
• 101000650600 Homo sapiens DNA-directed RNA polymerase I subunit RPA2 Proteins 0.000 description 1
• 101001106401 Homo sapiens DNA-directed RNA polymerase II subunit RPB1 Proteins 0.000 description 1
• 101000624426 Homo sapiens Dual specificity mitogen-activated protein kinase kinase 6 Proteins 0.000 description 1
• 101001050451 Homo sapiens Elongation factor 1-gamma Proteins 0.000 description 1
• 101000967216 Homo sapiens Eosinophil cationic protein Proteins 0.000 description 1
• 101000997829 Homo sapiens Glial cell line-derived neurotrophic factor Proteins 0.000 description 1
• 101000926939 Homo sapiens Glucocorticoid receptor Proteins 0.000 description 1
• 101001024316 Homo sapiens Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 Proteins 0.000 description 1
• 101000857888 Homo sapiens Guanine nucleotide-binding protein G(q) subunit alpha Proteins 0.000 description 1
• 101001014590 Homo sapiens Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas Proteins 0.000 description 1
• 101001014594 Homo sapiens Guanine nucleotide-binding protein G(s) subunit alpha isoforms short Proteins 0.000 description 1
• 101000878611 Homo sapiens High affinity immunoglobulin epsilon receptor subunit alpha Proteins 0.000 description 1
• 101000824104 Homo sapiens High affinity immunoglobulin epsilon receptor subunit gamma Proteins 0.000 description 1
• 101000935040 Homo sapiens Integrin beta-2 Proteins 0.000 description 1
• 101001002634 Homo sapiens Interleukin-1 alpha Proteins 0.000 description 1
• 101000960952 Homo sapiens Interleukin-1 receptor accessory protein Proteins 0.000 description 1
• 101001076407 Homo sapiens Interleukin-1 receptor antagonist protein Proteins 0.000 description 1
• 101001033312 Homo sapiens Interleukin-4 receptor subunit alpha Proteins 0.000 description 1
• 101000599048 Homo sapiens Interleukin-6 receptor subunit alpha Proteins 0.000 description 1
• 101001043809 Homo sapiens Interleukin-7 receptor subunit alpha Proteins 0.000 description 1
• 101001049181 Homo sapiens Killer cell lectin-like receptor subfamily B member 1 Proteins 0.000 description 1
• 101001005128 Homo sapiens LIM domain kinase 1 Proteins 0.000 description 1
• 101000984196 Homo sapiens Leukocyte immunoglobulin-like receptor subfamily A member 5 Proteins 0.000 description 1
• 101000984186 Homo sapiens Leukocyte immunoglobulin-like receptor subfamily B member 4 Proteins 0.000 description 1
• 101001017968 Homo sapiens Leukotriene B4 receptor 1 Proteins 0.000 description 1
• 101001044093 Homo sapiens Lipopolysaccharide-induced tumor necrosis factor-alpha factor Proteins 0.000 description 1
• 101001090688 Homo sapiens Lymphocyte cytosolic protein 2 Proteins 0.000 description 1
• 101001098256 Homo sapiens Lysophospholipase Proteins 0.000 description 1
• 101000573522 Homo sapiens MAP kinase-interacting serine/threonine-protein kinase 1 Proteins 0.000 description 1
• 101001018196 Homo sapiens Mitogen-activated protein kinase kinase kinase 5 Proteins 0.000 description 1
• 101001055092 Homo sapiens Mitogen-activated protein kinase kinase kinase 7 Proteins 0.000 description 1
• 101001076431 Homo sapiens NF-kappa-B inhibitor zeta Proteins 0.000 description 1
• 101000589301 Homo sapiens Natural cytotoxicity triggering receptor 1 Proteins 0.000 description 1
• 101001014610 Homo sapiens Neuroendocrine secretory protein 55 Proteins 0.000 description 1
• 101000979342 Homo sapiens Nuclear factor NF-kappa-B p105 subunit Proteins 0.000 description 1
• 101000594698 Homo sapiens Ornithine decarboxylase antizyme 1 Proteins 0.000 description 1
• 101001067833 Homo sapiens Peptidyl-prolyl cis-trans isomerase A Proteins 0.000 description 1
• 101001091194 Homo sapiens Peptidyl-prolyl cis-trans isomerase G Proteins 0.000 description 1
• 101000797903 Homo sapiens Protein ALEX Proteins 0.000 description 1
• 101001000069 Homo sapiens Protein phosphatase 1 regulatory subunit 12B Proteins 0.000 description 1
• 101000712530 Homo sapiens RAF proto-oncogene serine/threonine-protein kinase Proteins 0.000 description 1
• 101000848727 Homo sapiens Rap guanine nucleotide exchange factor 2 Proteins 0.000 description 1
• 101001109145 Homo sapiens Receptor-interacting serine/threonine-protein kinase 1 Proteins 0.000 description 1
• 101000945096 Homo sapiens Ribosomal protein S6 kinase alpha-5 Proteins 0.000 description 1
• 101000891084 Homo sapiens T-cell activation Rho GTPase-activating protein Proteins 0.000 description 1
• 101000763579 Homo sapiens Toll-like receptor 1 Proteins 0.000 description 1
• 101000831567 Homo sapiens Toll-like receptor 2 Proteins 0.000 description 1
• 101000669447 Homo sapiens Toll-like receptor 4 Proteins 0.000 description 1
• 101000669460 Homo sapiens Toll-like receptor 5 Proteins 0.000 description 1
• 101000962473 Homo sapiens Transcription factor MafG Proteins 0.000 description 1
• 101000635938 Homo sapiens Transforming growth factor beta-1 proprotein Proteins 0.000 description 1
• 101000638255 Homo sapiens Tumor necrosis factor ligand superfamily member 8 Proteins 0.000 description 1
• 101000851376 Homo sapiens Tumor necrosis factor receptor superfamily member 8 Proteins 0.000 description 1
• 101000850748 Homo sapiens Tumor necrosis factor receptor type 1-associated DEATH domain protein Proteins 0.000 description 1
• 101000934996 Homo sapiens Tyrosine-protein kinase JAK3 Proteins 0.000 description 1
• 101000760337 Homo sapiens Urokinase plasminogen activator surface receptor Proteins 0.000 description 1
• 108010070875 Human Immunodeficiency Virus tat Gene Products Proteins 0.000 description 1
• 206010020751 Hypersensitivity Diseases 0.000 description 1
• 208000006083 Hypokinesia Diseases 0.000 description 1
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
• 108060003951 Immunoglobulin Proteins 0.000 description 1
• 102000017727 Immunoglobulin Variable Region Human genes 0.000 description 1
• 108010067060 Immunoglobulin Variable Region Proteins 0.000 description 1
• 229930010555 Inosine Natural products 0.000 description 1
• UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
• 102100025390 Integrin beta-2 Human genes 0.000 description 1
• 102000003996 Interferon-beta Human genes 0.000 description 1
• 108090000467 Interferon-beta Proteins 0.000 description 1
• 102100020881 Interleukin-1 alpha Human genes 0.000 description 1
• 102100039880 Interleukin-1 receptor accessory protein Human genes 0.000 description 1
• 102100026018 Interleukin-1 receptor antagonist protein Human genes 0.000 description 1
• 102000003814 Interleukin-10 Human genes 0.000 description 1
• 108090000174 Interleukin-10 Proteins 0.000 description 1
• 102000003812 Interleukin-15 Human genes 0.000 description 1
• 108090000172 Interleukin-15 Proteins 0.000 description 1
• 102000003810 Interleukin-18 Human genes 0.000 description 1
• 108090000171 Interleukin-18 Proteins 0.000 description 1
• 102100039078 Interleukin-4 receptor subunit alpha Human genes 0.000 description 1
• 102100037792 Interleukin-6 receptor subunit alpha Human genes 0.000 description 1
• 102100021593 Interleukin-7 receptor subunit alpha Human genes 0.000 description 1
• 206010022998 Irritability Diseases 0.000 description 1
• 108090000484 Kelch-Like ECH-Associated Protein 1 Proteins 0.000 description 1
• 102000004034 Kelch-Like ECH-Associated Protein 1 Human genes 0.000 description 1
• 102100023678 Killer cell lectin-like receptor subfamily B member 1 Human genes 0.000 description 1
• 102100026023 LIM domain kinase 1 Human genes 0.000 description 1
• 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
• 240000007472 Leucaena leucocephala Species 0.000 description 1
• 102100025574 Leukocyte immunoglobulin-like receptor subfamily A member 5 Human genes 0.000 description 1
• 102100025578 Leukocyte immunoglobulin-like receptor subfamily B member 4 Human genes 0.000 description 1
• 102100033374 Leukotriene B4 receptor 1 Human genes 0.000 description 1
• 102100021607 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human genes 0.000 description 1
• 102100034709 Lymphocyte cytosolic protein 2 Human genes 0.000 description 1
• 102100037611 Lysophospholipase Human genes 0.000 description 1
• 108010075654 MAP Kinase Kinase Kinase 1 Proteins 0.000 description 1
• 102100026299 MAP kinase-interacting serine/threonine-protein kinase 1 Human genes 0.000 description 1
• 108700012928 MAPK14 Proteins 0.000 description 1
• 102100028123 Macrophage colony-stimulating factor 1 Human genes 0.000 description 1
• 101150117406 Mafk gene Proteins 0.000 description 1
• 101150003941 Mapk14 gene Proteins 0.000 description 1
• 208000026139 Memory disease Diseases 0.000 description 1
• 102000054819 Mitogen-activated protein kinase 14 Human genes 0.000 description 1
• 102100033115 Mitogen-activated protein kinase kinase kinase 1 Human genes 0.000 description 1
• 102100033127 Mitogen-activated protein kinase kinase kinase 5 Human genes 0.000 description 1
• 102100026888 Mitogen-activated protein kinase kinase kinase 7 Human genes 0.000 description 1
• 206010027951 Mood swings Diseases 0.000 description 1
• 208000007101 Muscle Cramp Diseases 0.000 description 1
• 208000029578 Muscle disease Diseases 0.000 description 1
• 208000021642 Muscular disease Diseases 0.000 description 1
• 208000023178 Musculoskeletal disease Diseases 0.000 description 1
• 102100021148 Myocyte-specific enhancer factor 2A Human genes 0.000 description 1
• 102100039212 Myocyte-specific enhancer factor 2D Human genes 0.000 description 1
• 108010071382 NF-E2-Related Factor 2 Proteins 0.000 description 1
• 102000003945 NF-kappa B Human genes 0.000 description 1
• 108010057466 NF-kappa B Proteins 0.000 description 1
• 102100026009 NF-kappa-B inhibitor zeta Human genes 0.000 description 1
• 102100032870 Natural cytotoxicity triggering receptor 1 Human genes 0.000 description 1
• 208000025966 Neurological disease Diseases 0.000 description 1
• 102100023050 Nuclear factor NF-kappa-B p105 subunit Human genes 0.000 description 1
• 102100031701 Nuclear factor erythroid 2-related factor 2 Human genes 0.000 description 1
• 108091005461 Nucleic proteins Proteins 0.000 description 1
• 229910004679 ONO2 Inorganic materials 0.000 description 1
• 239000005642 Oleic acid Substances 0.000 description 1
• ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
• 102100036199 Ornithine decarboxylase antizyme 1 Human genes 0.000 description 1
• 240000007594 Oryza sativa Species 0.000 description 1
• 235000007164 Oryza sativa Nutrition 0.000 description 1
• 102100024894 PR domain zinc finger protein 1 Human genes 0.000 description 1
• 101150084398 PTAFR gene Proteins 0.000 description 1
• 239000005662 Paraffin oil Substances 0.000 description 1
• 206010033799 Paralysis Diseases 0.000 description 1
• 235000019483 Peanut oil Nutrition 0.000 description 1
• 102100034539 Peptidyl-prolyl cis-trans isomerase A Human genes 0.000 description 1
• 102100034850 Peptidyl-prolyl cis-trans isomerase G Human genes 0.000 description 1
• 108090000029 Peroxisome Proliferator-Activated Receptors Proteins 0.000 description 1
• 102100038831 Peroxisome proliferator-activated receptor alpha Human genes 0.000 description 1
• PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 1
• ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical class OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 1
• OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
• 108700023400 Platelet-activating factor receptors Proteins 0.000 description 1
• 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
• 229920002730 Poly(butyl cyanoacrylate) Polymers 0.000 description 1
• 108010009975 Positive Regulatory Domain I-Binding Factor 1 Proteins 0.000 description 1
• 102100038280 Prostaglandin G/H synthase 2 Human genes 0.000 description 1
• 102100029812 Protein S100-A12 Human genes 0.000 description 1
• 101710110949 Protein S100-A12 Proteins 0.000 description 1
• 102100036545 Protein phosphatase 1 regulatory subunit 12B Human genes 0.000 description 1
• CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
• 102100033479 RAF proto-oncogene serine/threonine-protein kinase Human genes 0.000 description 1
• 101710086015 RNA ligase Proteins 0.000 description 1
• 230000026279 RNA modification Effects 0.000 description 1
• MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
• 102100034585 Rap guanine nucleotide exchange factor 2 Human genes 0.000 description 1
• 102100022122 Ras-related C3 botulinum toxin substrate 1 Human genes 0.000 description 1
• 108010079933 Receptor-Interacting Protein Serine-Threonine Kinase 2 Proteins 0.000 description 1
• 102100022501 Receptor-interacting serine/threonine-protein kinase 1 Human genes 0.000 description 1
• 102100022502 Receptor-interacting serine/threonine-protein kinase 2 Human genes 0.000 description 1
• 108091028664 Ribonucleotide Proteins 0.000 description 1
• PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
• 102100033645 Ribosomal protein S6 kinase alpha-5 Human genes 0.000 description 1
• 102100025373 Runt-related transcription factor 1 Human genes 0.000 description 1
• 102100022340 SHC-transforming protein 1 Human genes 0.000 description 1
• 206010041243 Social avoidant behaviour Diseases 0.000 description 1
• 101150045565 Socs1 gene Proteins 0.000 description 1
• VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
• 244000061456 Solanum tuberosum Species 0.000 description 1
• 235000002595 Solanum tuberosum Nutrition 0.000 description 1
• 206010041347 Somnambulism Diseases 0.000 description 1
• PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical class CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 description 1
• 101100054666 Streptomyces halstedii sch3 gene Proteins 0.000 description 1
• 208000006011 Stroke Diseases 0.000 description 1
• UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
• 108700027336 Suppressor of Cytokine Signaling 1 Proteins 0.000 description 1
• 102100024779 Suppressor of cytokine signaling 1 Human genes 0.000 description 1
• 102100040346 T-cell activation Rho GTPase-activating protein Human genes 0.000 description 1
• 210000001744 T-lymphocyte Anatomy 0.000 description 1
• 102000004399 TNF receptor-associated factor 3 Human genes 0.000 description 1
• 108090000922 TNF receptor-associated factor 3 Proteins 0.000 description 1
• 241001365914 Taira Species 0.000 description 1
• 102100027010 Toll-like receptor 1 Human genes 0.000 description 1
• 102100024333 Toll-like receptor 2 Human genes 0.000 description 1
• 102100039360 Toll-like receptor 4 Human genes 0.000 description 1
• 102100039357 Toll-like receptor 5 Human genes 0.000 description 1
• 102000003929 Transaminases Human genes 0.000 description 1
• 108090000340 Transaminases Proteins 0.000 description 1
• 108010057666 Transcription Factor CHOP Proteins 0.000 description 1
• 102000040945 Transcription factor Human genes 0.000 description 1
• 108091023040 Transcription factor Proteins 0.000 description 1
• 102100039188 Transcription factor MafG Human genes 0.000 description 1
• 102100039190 Transcription factor MafK Human genes 0.000 description 1
• 102100027654 Transcription factor PU.1 Human genes 0.000 description 1
• 108010040625 Transforming Protein 1 Src Homology 2 Domain-Containing Proteins 0.000 description 1
• 102100030742 Transforming growth factor beta-1 proprotein Human genes 0.000 description 1
• 102000056172 Transforming growth factor beta-3 Human genes 0.000 description 1
• 108090000097 Transforming growth factor beta-3 Proteins 0.000 description 1
• HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
• 206010044565 Tremor Diseases 0.000 description 1
• 235000021307 Triticum Nutrition 0.000 description 1
• 244000098338 Triticum aestivum Species 0.000 description 1
• 108010065158 Tumor Necrosis Factor Ligand Superfamily Member 14 Proteins 0.000 description 1
• 102100024586 Tumor necrosis factor ligand superfamily member 14 Human genes 0.000 description 1
• 102100032100 Tumor necrosis factor ligand superfamily member 8 Human genes 0.000 description 1
• 102100036857 Tumor necrosis factor receptor superfamily member 8 Human genes 0.000 description 1
• 102100033081 Tumor necrosis factor receptor type 1-associated DEATH domain protein Human genes 0.000 description 1
• 102100025387 Tyrosine-protein kinase JAK3 Human genes 0.000 description 1
• MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
• 102100024689 Urokinase plasminogen activator surface receptor Human genes 0.000 description 1
• 241000700647 Variola virus Species 0.000 description 1
• 208000012886 Vertigo Diseases 0.000 description 1
• 240000008042 Zea mays Species 0.000 description 1
• 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
• 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
• WERKSKAQRVDLDW-ANOHMWSOSA-N [(2s,3r,4r,5r)-2,3,4,5,6-pentahydroxyhexyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO WERKSKAQRVDLDW-ANOHMWSOSA-N 0.000 description 1
• HIHOWBSBBDRPDW-PTHRTHQKSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] n-[2-(dimethylamino)ethyl]carbamate Chemical compound C1C=C2C[C@@H](OC(=O)NCCN(C)C)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HIHOWBSBBDRPDW-PTHRTHQKSA-N 0.000 description 1
• 230000002159 abnormal effect Effects 0.000 description 1
• 230000004598 abnormal eye movement Effects 0.000 description 1
• 238000010521 absorption reaction Methods 0.000 description 1
• XVIYCJDWYLJQBG-UHFFFAOYSA-N acetic acid;adamantane Chemical compound CC(O)=O.C1C(C2)CC3CC1CC2C3 XVIYCJDWYLJQBG-UHFFFAOYSA-N 0.000 description 1
• 239000003377 acid catalyst Substances 0.000 description 1
• 230000003213 activating effect Effects 0.000 description 1
• 239000008272 agar Substances 0.000 description 1
• 235000010419 agar Nutrition 0.000 description 1
• 238000011256 aggressive treatment Methods 0.000 description 1
• 235000010443 alginic acid Nutrition 0.000 description 1
• 239000000783 alginic acid Substances 0.000 description 1
• 229920000615 alginic acid Polymers 0.000 description 1
• 229960001126 alginic acid Drugs 0.000 description 1
• 150000004781 alginic acids Chemical class 0.000 description 1
• 150000001336 alkenes Chemical class 0.000 description 1
• 125000005083 alkoxyalkoxy group Chemical group 0.000 description 1
• 125000002877 alkyl aryl group Chemical group 0.000 description 1
• 125000005600 alkyl phosphonate group Chemical group 0.000 description 1
• 125000002947 alkylene group Chemical group 0.000 description 1
• 208000026935 allergic disease Diseases 0.000 description 1
• 230000007815 allergy Effects 0.000 description 1
• HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
• HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
• VREFGVBLTWBCJP-UHFFFAOYSA-N alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 description 1
• 230000004075 alteration Effects 0.000 description 1
• DKNWSYNQZKUICI-UHFFFAOYSA-N amantadine Chemical compound C1C(C2)CC3CC2CC1(N)C3 DKNWSYNQZKUICI-UHFFFAOYSA-N 0.000 description 1
• 229960003805 amantadine Drugs 0.000 description 1
• 150000001413 amino acids Chemical group 0.000 description 1
• 125000005122 aminoalkylamino group Chemical group 0.000 description 1
• 230000003321 amplification Effects 0.000 description 1
• 210000003423 ankle Anatomy 0.000 description 1
• PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
• 150000004056 anthraquinones Chemical class 0.000 description 1
• 230000003078 antioxidant effect Effects 0.000 description 1
• 239000003816 antisense DNA Substances 0.000 description 1
• 230000036506 anxiety Effects 0.000 description 1
• 230000036528 appetite Effects 0.000 description 1
• 235000019789 appetite Nutrition 0.000 description 1
• 210000000617 arm Anatomy 0.000 description 1
• 125000003710 aryl alkyl group Chemical group 0.000 description 1
• 229960005070 ascorbic acid Drugs 0.000 description 1
• 235000010323 ascorbic acid Nutrition 0.000 description 1
• 239000011668 ascorbic acid Substances 0.000 description 1
• 239000000605 aspartame Substances 0.000 description 1
• IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
• 235000010357 aspartame Nutrition 0.000 description 1
• 229960003438 aspartame Drugs 0.000 description 1
• 238000003556 assay Methods 0.000 description 1
• 208000006673 asthma Diseases 0.000 description 1
• 210000001130 astrocyte Anatomy 0.000 description 1
• 125000004429 atom Chemical group 0.000 description 1
• 210000003050 axon Anatomy 0.000 description 1
• 238000002869 basic local alignment search tool Methods 0.000 description 1
• 235000013871 bee wax Nutrition 0.000 description 1
• 239000012166 beeswax Substances 0.000 description 1
• 230000009286 beneficial effect Effects 0.000 description 1
• ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
• HMFHBZSHGGEWLO-TXICZTDVSA-N beta-D-ribose Chemical group OC[C@H]1O[C@@H](O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-TXICZTDVSA-N 0.000 description 1
• 230000008236 biological pathway Effects 0.000 description 1
• 239000003914 blood derivative Substances 0.000 description 1
• 210000004204 blood vessel Anatomy 0.000 description 1
• 230000036760 body temperature Effects 0.000 description 1
• 238000006664 bond formation reaction Methods 0.000 description 1
• 238000009395 breeding Methods 0.000 description 1
• 230000001488 breeding effect Effects 0.000 description 1
• 239000000872 buffer Substances 0.000 description 1
• 239000006172 buffering agent Substances 0.000 description 1
• 239000011575 calcium Substances 0.000 description 1
• 239000001110 calcium chloride Substances 0.000 description 1
• 229910001628 calcium chloride Inorganic materials 0.000 description 1
• 235000011148 calcium chloride Nutrition 0.000 description 1
• 238000004364 calculation method Methods 0.000 description 1
• 150000001720 carbohydrates Chemical class 0.000 description 1
• 235000014633 carbohydrates Nutrition 0.000 description 1
• 229910052799 carbon Inorganic materials 0.000 description 1
• 239000000969 carrier Substances 0.000 description 1
• 108010051348 cdc42 GTP-Binding Protein Proteins 0.000 description 1
• VAAUVRVFOQPIGI-SPQHTLEESA-N ceftriaxone Chemical compound S([C@@H]1[C@@H](C(N1C=1C(O)=O)=O)NC(=O)\C(=N/OC)C=2N=C(N)SC=2)CC=1CSC1=NC(=O)C(=O)NN1C VAAUVRVFOQPIGI-SPQHTLEESA-N 0.000 description 1
• 229960004755 ceftriaxone Drugs 0.000 description 1
• 238000012832 cell culture technique Methods 0.000 description 1
• 108091092328 cellular RNA Proteins 0.000 description 1
• 230000019522 cellular metabolic process Effects 0.000 description 1
• 229920002678 cellulose Polymers 0.000 description 1
• 239000001913 cellulose Substances 0.000 description 1
• 210000003169 central nervous system Anatomy 0.000 description 1
• 229960000541 cetyl alcohol Drugs 0.000 description 1
• 230000001055 chewing effect Effects 0.000 description 1
• 150000001841 cholesterols Chemical class 0.000 description 1
• 208000012601 choreatic disease Diseases 0.000 description 1
• 239000007979 citrate buffer Substances 0.000 description 1
• 238000011260 co-administration Methods 0.000 description 1
• 239000011248 coating agent Substances 0.000 description 1
• 229940110456 cocoa butter Drugs 0.000 description 1
• 235000019868 cocoa butter Nutrition 0.000 description 1
• 239000003240 coconut oil Substances 0.000 description 1
• 235000019864 coconut oil Nutrition 0.000 description 1
• 229920001436 collagen Polymers 0.000 description 1
• 238000010835 comparative analysis Methods 0.000 description 1
• JECGPMYZUFFYJW-UHFFFAOYSA-N conferone Natural products CC1=CCC2C(C)(C)C(=O)CCC2(C)C1COc3cccc4C=CC(=O)Oc34 JECGPMYZUFFYJW-UHFFFAOYSA-N 0.000 description 1
• 238000012790 confirmation Methods 0.000 description 1
• 230000008602 contraction Effects 0.000 description 1
• 238000013270 controlled release Methods 0.000 description 1
• 235000005822 corn Nutrition 0.000 description 1
• 239000003246 corticosteroid Substances 0.000 description 1
• 229960001334 corticosteroids Drugs 0.000 description 1
• 235000001671 coumarin Nutrition 0.000 description 1
• 150000004775 coumarins Chemical class 0.000 description 1
• 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
• 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 1
• 230000007850 degeneration Effects 0.000 description 1
• 230000003111 delayed effect Effects 0.000 description 1
• 238000001514 detection method Methods 0.000 description 1
• 239000003599 detergent Substances 0.000 description 1
• 150000005690 diesters Chemical class 0.000 description 1
• 230000004069 differentiation Effects 0.000 description 1
• 208000029444 double vision Diseases 0.000 description 1
• 241001493065 dsRNA viruses Species 0.000 description 1
• 239000000975 dye Substances 0.000 description 1
• 208000010118 dystonia Diseases 0.000 description 1
• 239000003974 emollient agent Substances 0.000 description 1
• 230000001804 emulsifying effect Effects 0.000 description 1
• 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
• 230000007717 exclusion Effects 0.000 description 1
• 230000029142 excretion Effects 0.000 description 1
• 239000013613 expression plasmid Substances 0.000 description 1
• 239000013604 expression vector Substances 0.000 description 1
• 239000010685 fatty oil Substances 0.000 description 1
• 229960000556 fingolimod Drugs 0.000 description 1
• KKGQTZUTZRNORY-UHFFFAOYSA-N fingolimod Chemical compound CCCCCCCCC1=CC=C(CCC(N)(CO)CO)C=C1 KKGQTZUTZRNORY-UHFFFAOYSA-N 0.000 description 1
• 229940014144 folate Drugs 0.000 description 1
• OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 1
• 235000019152 folic acid Nutrition 0.000 description 1
• 239000011724 folic acid Substances 0.000 description 1
• 235000012631 food intake Nutrition 0.000 description 1
• 210000002683 foot Anatomy 0.000 description 1
• 210000004744 fore-foot Anatomy 0.000 description 1
• 125000000524 functional group Chemical group 0.000 description 1
• 230000002538 fungal effect Effects 0.000 description 1
• 239000008273 gelatin Substances 0.000 description 1
• 229920000159 gelatin Polymers 0.000 description 1
• 235000019322 gelatine Nutrition 0.000 description 1
• 235000011852 gelatine desserts Nutrition 0.000 description 1
• 238000011223 gene expression profiling Methods 0.000 description 1
• 230000030279 gene silencing Effects 0.000 description 1
• 238000010353 genetic engineering Methods 0.000 description 1
• 229940042385 glatiramer Drugs 0.000 description 1
• 239000008202 granule composition Substances 0.000 description 1
• 238000000227 grinding Methods 0.000 description 1
• 239000001963 growth medium Substances 0.000 description 1
• 230000004886 head movement Effects 0.000 description 1
• 230000003862 health status Effects 0.000 description 1
• 125000000592 heterocycloalkyl group Chemical group 0.000 description 1
• FBPFZTCFMRRESA-UHFFFAOYSA-N hexane-1,2,3,4,5,6-hexol Chemical compound OCC(O)C(O)C(O)C(O)CO FBPFZTCFMRRESA-UHFFFAOYSA-N 0.000 description 1
• 230000003301 hydrolyzing effect Effects 0.000 description 1
• 230000002209 hydrophobic effect Effects 0.000 description 1
• 230000036039 immunity Effects 0.000 description 1
• 230000003053 immunization Effects 0.000 description 1
• 238000003119 immunoblot Methods 0.000 description 1
• 102000018358 immunoglobulin Human genes 0.000 description 1
• 229940027941 immunoglobulin g Drugs 0.000 description 1
• 230000001771 impaired effect Effects 0.000 description 1
• 239000007943 implant Substances 0.000 description 1
• 230000005032 impulse control Effects 0.000 description 1
• 238000007901 in situ hybridization Methods 0.000 description 1
• 238000000099 in vitro assay Methods 0.000 description 1
• 238000005462 in vivo assay Methods 0.000 description 1
• 238000010348 incorporation Methods 0.000 description 1
• 208000027866 inflammatory disease Diseases 0.000 description 1
• 229960003786 inosine Drugs 0.000 description 1
• 239000000138 intercalating agent Substances 0.000 description 1
• 238000007918 intramuscular administration Methods 0.000 description 1
• 238000007912 intraperitoneal administration Methods 0.000 description 1
• 238000007914 intraventricular administration Methods 0.000 description 1
• 238000002955 isolation Methods 0.000 description 1
• QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
• 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
• 235000015110 jellies Nutrition 0.000 description 1
• 238000011005 laboratory method Methods 0.000 description 1
• 230000002045 lasting effect Effects 0.000 description 1
• 235000010445 lecithin Nutrition 0.000 description 1
• 239000000787 lecithin Substances 0.000 description 1
• 229940067606 lecithin Drugs 0.000 description 1
• 210000002414 leg Anatomy 0.000 description 1
• 239000003446 ligand Substances 0.000 description 1
• 125000001921 locked nucleotide group Chemical group 0.000 description 1
• 208000018769 loss of vision Diseases 0.000 description 1
• 231100000864 loss of vision Toxicity 0.000 description 1
• 239000006210 lotion Substances 0.000 description 1
• 239000007937 lozenge Substances 0.000 description 1
• 239000012931 lyophilized formulation Substances 0.000 description 1
• 239000008176 lyophilized powder Substances 0.000 description 1
• 210000002540 macrophage Anatomy 0.000 description 1
• 210000004962 mammalian cell Anatomy 0.000 description 1
• 239000002609 medium Substances 0.000 description 1
• 239000000155 melt Substances 0.000 description 1
• 230000006984 memory degeneration Effects 0.000 description 1
• 208000023060 memory loss Diseases 0.000 description 1
• 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
• 238000007069 methylation reaction Methods 0.000 description 1
• IDBOAVAEGRJRIZ-UHFFFAOYSA-N methylidenehydrazine Chemical group NN=C IDBOAVAEGRJRIZ-UHFFFAOYSA-N 0.000 description 1
• 108091045790 miR-106b stem-loop Proteins 0.000 description 1
• 108091031326 miR-15b stem-loop Proteins 0.000 description 1
• 108091081505 miR-190 stem-loop Proteins 0.000 description 1
• 108091086834 miR-190-2 stem-loop Proteins 0.000 description 1
• 108091092825 miR-24 stem-loop Proteins 0.000 description 1
• 108091032978 miR-24-3 stem-loop Proteins 0.000 description 1
• 108091064025 miR-24-4 stem-loop Proteins 0.000 description 1
• 108091040861 miR-300 stem-loop Proteins 0.000 description 1
• 108091043187 miR-30a stem-loop Proteins 0.000 description 1
• 108091063344 miR-30b stem-loop Proteins 0.000 description 1
• 108091023108 miR-30e stem-loop Proteins 0.000 description 1
• 108091043186 miR-526a stem-loop Proteins 0.000 description 1
• 108091034304 miR-548b stem-loop Proteins 0.000 description 1
• 238000002493 microarray Methods 0.000 description 1
• 230000002025 microglial effect Effects 0.000 description 1
• DYKFCLLONBREIL-KVUCHLLUSA-N minocycline Chemical compound C([C@H]1C2)C3=C(N(C)C)C=CC(O)=C3C(=O)C1=C(O)[C@@]1(O)[C@@H]2[C@H](N(C)C)C(O)=C(C(N)=O)C1=O DYKFCLLONBREIL-KVUCHLLUSA-N 0.000 description 1
• 229960004023 minocycline Drugs 0.000 description 1
• KKZJGLLVHKMTCM-UHFFFAOYSA-N mitoxantrone Chemical compound O=C1C2=C(O)C=CC(O)=C2C(=O)C2=C1C(NCCNCCO)=CC=C2NCCNCCO KKZJGLLVHKMTCM-UHFFFAOYSA-N 0.000 description 1
• 229960001156 mitoxantrone Drugs 0.000 description 1
• 238000002156 mixing Methods 0.000 description 1
• 238000006011 modification reaction Methods 0.000 description 1
• 238000001823 molecular biology technique Methods 0.000 description 1
• 238000003032 molecular docking Methods 0.000 description 1
• 239000000178 monomer Substances 0.000 description 1
• 210000005087 mononuclear cell Anatomy 0.000 description 1
• 210000002161 motor neuron Anatomy 0.000 description 1
• 230000004118 muscle contraction Effects 0.000 description 1
• 229940035363 muscle relaxants Drugs 0.000 description 1
• 210000000066 myeloid cell Anatomy 0.000 description 1
• 208000031225 myocardial ischemia Diseases 0.000 description 1
• 239000003158 myorelaxant agent Substances 0.000 description 1
• GZCNJTFELNTSAB-UHFFFAOYSA-N n'-(7h-purin-6-yl)hexane-1,6-diamine Chemical compound NCCCCCCNC1=NC=NC2=C1NC=N2 GZCNJTFELNTSAB-UHFFFAOYSA-N 0.000 description 1
• DAZXVJBJRMWXJP-UHFFFAOYSA-N n,n-dimethylethylamine Chemical compound CCN(C)C DAZXVJBJRMWXJP-UHFFFAOYSA-N 0.000 description 1
• DAZSWUUAFHBCGE-KRWDZBQOSA-N n-[(2s)-3-methyl-1-oxo-1-pyrrolidin-1-ylbutan-2-yl]-3-phenylpropanamide Chemical compound N([C@@H](C(C)C)C(=O)N1CCCC1)C(=O)CCC1=CC=CC=C1 DAZSWUUAFHBCGE-KRWDZBQOSA-N 0.000 description 1
• 229960005027 natalizumab Drugs 0.000 description 1
• 229920001206 natural gum Polymers 0.000 description 1
• 210000000822 natural killer cell Anatomy 0.000 description 1
• 210000005036 nerve Anatomy 0.000 description 1
• 210000004498 neuroglial cell Anatomy 0.000 description 1
• 210000002569 neuron Anatomy 0.000 description 1
• 230000003955 neuronal function Effects 0.000 description 1
• 125000001893 nitrooxy group Chemical group [O-][N+](=O)O* 0.000 description 1
• 231100000344 non-irritating Toxicity 0.000 description 1
• 230000009871 nonspecific binding Effects 0.000 description 1
• 238000010606 normalization Methods 0.000 description 1
• 238000003199 nucleic acid amplification method Methods 0.000 description 1
• 230000001293 nucleolytic effect Effects 0.000 description 1
• GYCKQBWUSACYIF-UHFFFAOYSA-N o-hydroxybenzoic acid ethyl ester Natural products CCOC(=O)C1=CC=CC=C1O GYCKQBWUSACYIF-UHFFFAOYSA-N 0.000 description 1
• 239000012053 oil suspension Substances 0.000 description 1
• 239000002674 ointment Substances 0.000 description 1
• 229940049964 oleate Drugs 0.000 description 1
• ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
• 229940046166 oligodeoxynucleotide Drugs 0.000 description 1
• 238000002515 oligonucleotide synthesis Methods 0.000 description 1
• 239000004006 olive oil Substances 0.000 description 1
• 235000008390 olive oil Nutrition 0.000 description 1
• 238000005457 optimization Methods 0.000 description 1
• 239000003960 organic solvent Substances 0.000 description 1
• 125000001181 organosilyl group Chemical group [SiH3]* 0.000 description 1
• 239000001301 oxygen Substances 0.000 description 1
• 239000003002 pH adjusting agent Substances 0.000 description 1
• 239000012188 paraffin wax Substances 0.000 description 1
• 230000001575 pathological effect Effects 0.000 description 1
• 239000000312 peanut oil Substances 0.000 description 1
• 239000002304 perfume Substances 0.000 description 1
• 210000001428 peripheral nervous system Anatomy 0.000 description 1
• 230000035699 permeability Effects 0.000 description 1
• 239000000825 pharmaceutical preparation Substances 0.000 description 1
• 230000000144 pharmacologic effect Effects 0.000 description 1
• 150000004713 phosphodiesters Chemical group 0.000 description 1
• 150000008298 phosphoramidates Chemical class 0.000 description 1
• 125000004437 phosphorous atom Chemical group 0.000 description 1
• 239000011574 phosphorus Substances 0.000 description 1
• 238000000554 physical therapy Methods 0.000 description 1
• 238000002616 plasmapheresis Methods 0.000 description 1
• 102000030769 platelet activating factor receptor Human genes 0.000 description 1
• 229920000570 polyether Polymers 0.000 description 1
• 229920000642 polymer Polymers 0.000 description 1
• 239000001103 potassium chloride Substances 0.000 description 1
• 235000011164 potassium chloride Nutrition 0.000 description 1
• 230000002335 preservative effect Effects 0.000 description 1
• 230000002265 prevention Effects 0.000 description 1
• 108091007428 primary miRNA Proteins 0.000 description 1
• 230000008569 process Effects 0.000 description 1
• 108090000765 processed proteins & peptides Proteins 0.000 description 1
• 230000000069 prophylactic effect Effects 0.000 description 1
• 108010008929 proto-oncogene protein Spi-1 Proteins 0.000 description 1
• 150000003212 purines Chemical class 0.000 description 1
• 108010062302 rac1 GTP Binding Protein Proteins 0.000 description 1
• MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
• 238000003259 recombinant expression Methods 0.000 description 1
• 230000007115 recruitment Effects 0.000 description 1
• 108091008146 restriction endonucleases Proteins 0.000 description 1
• 230000002441 reversible effect Effects 0.000 description 1
• 239000002336 ribonucleotide Substances 0.000 description 1
• 235000009566 rice Nutrition 0.000 description 1
• 229940072169 rilutek Drugs 0.000 description 1
• CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
• 235000019204 saccharin Nutrition 0.000 description 1
• 229940081974 saccharin Drugs 0.000 description 1
• 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
• 235000019515 salmon Nutrition 0.000 description 1
• 238000009738 saturating Methods 0.000 description 1
• 210000003786 sclera Anatomy 0.000 description 1
• 230000008684 selective degradation Effects 0.000 description 1
• 230000001953 sensory effect Effects 0.000 description 1
• 210000001044 sensory neuron Anatomy 0.000 description 1
• 238000012163 sequencing technique Methods 0.000 description 1
• 210000002966 serum Anatomy 0.000 description 1
• 239000008159 sesame oil Substances 0.000 description 1
• 235000011803 sesame oil Nutrition 0.000 description 1
• 239000000377 silicon dioxide Substances 0.000 description 1
• 210000003625 skull Anatomy 0.000 description 1
• 230000007958 sleep Effects 0.000 description 1
• 230000004599 slow eye movement Effects 0.000 description 1
• 229910052708 sodium Inorganic materials 0.000 description 1
• 239000011734 sodium Substances 0.000 description 1
• 235000015424 sodium Nutrition 0.000 description 1
• 239000001632 sodium acetate Substances 0.000 description 1
• 235000017281 sodium acetate Nutrition 0.000 description 1
• 239000001540 sodium lactate Substances 0.000 description 1
• 229940005581 sodium lactate Drugs 0.000 description 1
• 235000011088 sodium lactate Nutrition 0.000 description 1
• SRWFBFUYENBCGF-UHFFFAOYSA-M sodium;chloride;hydrochloride Chemical compound [Na+].Cl.[Cl-] SRWFBFUYENBCGF-UHFFFAOYSA-M 0.000 description 1
• 239000007901 soft capsule Substances 0.000 description 1
• 235000011069 sorbitan monooleate Nutrition 0.000 description 1
• 239000001593 sorbitan monooleate Substances 0.000 description 1
• 229940035049 sorbitan monooleate Drugs 0.000 description 1
• 239000008347 soybean phospholipid Substances 0.000 description 1
• 241000894007 species Species 0.000 description 1
• 238000010561 standard procedure Methods 0.000 description 1
• 239000008107 starch Substances 0.000 description 1
• 238000007619 statistical method Methods 0.000 description 1
• 230000001954 sterilising effect Effects 0.000 description 1
• 238000004659 sterilization and disinfection Methods 0.000 description 1
• 238000007920 subcutaneous administration Methods 0.000 description 1
• 125000001424 substituent group Chemical group 0.000 description 1
• 229960004793 sucrose Drugs 0.000 description 1
• 150000008163 sugars Chemical class 0.000 description 1
• IIACRCGMVDHOTQ-UHFFFAOYSA-N sulfamic acid Chemical group NS(O)(=O)=O IIACRCGMVDHOTQ-UHFFFAOYSA-N 0.000 description 1
• 150000003456 sulfonamides Chemical group 0.000 description 1
• BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
• 150000003457 sulfones Chemical group 0.000 description 1
• 150000003462 sulfoxides Chemical class 0.000 description 1
• 229910052717 sulfur Inorganic materials 0.000 description 1
• 230000004083 survival effect Effects 0.000 description 1
• 230000002459 sustained effect Effects 0.000 description 1
• 230000009747 swallowing Effects 0.000 description 1
• 238000003786 synthesis reaction Methods 0.000 description 1
• 239000000454 talc Substances 0.000 description 1
• 229910052623 talc Inorganic materials 0.000 description 1
• 230000002123 temporal effect Effects 0.000 description 1
• 239000002562 thickening agent Substances 0.000 description 1
• 210000003371 toe Anatomy 0.000 description 1
• 235000010487 tragacanth Nutrition 0.000 description 1
• 239000000196 tragacanth Substances 0.000 description 1
• 229940116362 tragacanth Drugs 0.000 description 1
• 238000012546 transfer Methods 0.000 description 1
• 230000009466 transformation Effects 0.000 description 1
• 238000013519 translation Methods 0.000 description 1
• 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 1
• 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
• 230000007306 turnover Effects 0.000 description 1
• 238000007492 two-way ANOVA Methods 0.000 description 1
• 241000701161 unidentified adenovirus Species 0.000 description 1
• 241001529453 unidentified herpesvirus Species 0.000 description 1
• 238000011144 upstream manufacturing Methods 0.000 description 1
• 238000010200 validation analysis Methods 0.000 description 1
• 231100000889 vertigo Toxicity 0.000 description 1
• 230000003612 virological effect Effects 0.000 description 1
• 230000004393 visual impairment Effects 0.000 description 1
• 230000003442 weekly effect Effects 0.000 description 1
• 229940075420 xanthine Drugs 0.000 description 1
• 210000005253 yeast cell Anatomy 0.000 description 1